Pulmoray infections due to Legionella pneumophila in immunocompromised patients

Pulmoray infections due to Legionella pneumophila in immunocompromised patients

The numbers of immunocom-promised individuals increase as programmes for organ transplantation and chemotherapy of malignant disease advance. Pulmonary infections, which progress rapidly, are one of the major clinical problems in these groups. This study was designed to evaluate the microbiology of pneumonia in immunocompromised patients and to determine the role of Legionella pneumophila. Immunocompromised patients receiving antineoplastic chemotherapy, diagnosed as pneumonia with clinical and radiographic findings and routine laboratory tests were included in the study. For microbiological diagnosis, expectorated sputum was cultured for L. pneumophila. In addition to standard bacterial, fungal and mycobacterial media, specimens were examined microscopically. Direct flourescent antibody (DFA) assay was used for antigen detection of L. pneumophila. By indirect flourescent antibody (IFA) assay the sera of the patients were screened for L. pneumophila. Of 74 sputum samples, 7 (9.5%) specimens yielded L. pneumophila. The other isolates were Escherichia coli (n:3), Enterobacter sp. (n:2), Aspergillus sp. (n:3), Mycobacterium tuberculosis (n:3), Staphylococcus aureus (n:1), yeasts (n:10), Nocardia sp. (n:2) and flora members (n:43). Antibiotic supplemented media and acid treatment was found superior for the isolation of L. pneumophila. Direct microscopic evaluation was necessary to support the culture results. DFA assay had 85% sensitivity and 100% specificity. Of 3 sera screened by IFA for L. pneumophila antibodies, 2 had the titres 1/256, indicating the disease. Our results showed that L. pneumophila has an important role among the respiratory pathogens in immunocompromised patients, and it may be useful if techniques for isolation and identification of this pathogen are added to routine culturing programmes.

___

  • 1. Schimpff SC. Infections in the cancer patient- Diagnosis, prevention and treatment. Mandell, Douglas and BennettsÕ Principles and Practice of Infectious Diseases (Eds. Mandell GL, Bennett Je, Dolin R.) 4th ed Vol 2 Churchill Livingstone, New York, 1995, pp: 2666-2675.
  • 2. Hopkin JM. Respiratory disease in the immuncompromised host. Non-AIDS. Respiratory Medicine (Eds. Brews RAL, Gibson GL, Gedde DM) Bailliere Tindoll WB Saunders, 1990, pp: 961-73.
  • 3. Mundy LM, Auwaerter PG, Oldach D, Warner ML, Burton A, Vance E, Gaydos CA, Joseph JM, Gopalan R, Moore R., Quino TC, Charache P, Bartlett JG: Community-acquired pneumonia: Impact of Immune status, Am J Respir Crit Care Med 152: 1309-1315, 1995.
  • 4. Baron EJ, Peterson LR, Finegold SM. Bailey and ScottÕs Diagnostic Microbiology. 9th ed Mosby Co., USA, 1994, pp: 570-575.
  • 5. Edelstein P. LegionnairesÕ disease. Clin Infect Dis 16: 741-747, 1993.
  • 6. Yu VL. Legionella pneumophilia (LegionnairesÕ Disease) Mandell, Douglas and BennettsÕ Principles and Practice of Infectious Diseases (Eds. Mandell GL, Bennett JE, Dolin R). 4th ed. Vol 2 Churchill Livingstone, New York, 1995, pp: 2087, 2097.
  • 7. Meyer RD, Edelstein PH, Kirby BD, Louie MH, Mulligan ME, Morgenstein AA, Finegold JM. LegionnairesÕ disease. Unusual clinical and laboratory features, Ann Intern Med 93: 240-243, 1980.
  • 8. Meunier F. Infections in patient with acute leukemia and lymphoma. Mandell, Douglas and BennettsÕ Principles and Practice of Infectious Diseases (Eds. Mandell GL, Bennett JE, Dolin R) 4th ed. Vol 2 Churchill Livingstone, New York, 1995, pp: 2675-2686.
  • 9. Mandell LA. Community-acquired pneumonia. Etiology, epidemiology and treatment, Chest 108: 355-425, 1995.
  • 10. Woodhead MA, MacFarlane JT, Rodgers FG. Aetiology and outcome of severe community aquired pneumonia. J Infect Dis 10: 204-210, 1985.
  • 11. Kerr E, Snell H, Black BL, Storey M, Colby WD. Isolation of Nocardia asteroides from respiratory specimens by using selective buffered charcoalyeast extract agar J Clin Microbiol 30(5): 1320-1322, 1992.
  • 12. Vickers RM, Rish JD, Yu VL. Clinical demonstration of isolation of Nocardia asteroides on buffered charcoal-yeast extract media. J Clin Microbiol 30(1): 227-228, 1992.
  • 13. Garrett MA, Holmes HT, Nolte FS. Selective buffered charcoal-yeast extract medium for isolation of Nocardia from mixed cultures. J Clin Microbiol 30(7): 1891-1892, 1992.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK